Brian Thomas Kalish, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoxia-Ischemia, Brain | 2 | 2024 | 352 | 0.890 |
Why?
|
Fatty Acids, Omega-3 | 4 | 2015 | 1392 | 0.740 |
Why?
|
Fetus | 5 | 2024 | 1864 | 0.740 |
Why?
|
Hypoplastic Left Heart Syndrome | 3 | 2017 | 594 | 0.700 |
Why?
|
Geniculate Bodies | 2 | 2018 | 160 | 0.690 |
Why?
|
Atrial Septum | 2 | 2017 | 60 | 0.590 |
Why?
|
Dobutamine | 1 | 2017 | 116 | 0.550 |
Why?
|
Milrinone | 1 | 2017 | 86 | 0.540 |
Why?
|
Auditory Cortex | 1 | 2020 | 363 | 0.520 |
Why?
|
Down Syndrome | 2 | 2023 | 900 | 0.510 |
Why?
|
Prenatal Exposure Delayed Effects | 2 | 2020 | 2508 | 0.500 |
Why?
|
Eicosanoids | 2 | 2013 | 282 | 0.470 |
Why?
|
Brain Injuries | 2 | 2023 | 2053 | 0.460 |
Why?
|
Methylmercury Compounds | 1 | 2014 | 103 | 0.440 |
Why?
|
RNA | 2 | 2020 | 2723 | 0.440 |
Why?
|
Fetal Heart | 2 | 2017 | 281 | 0.440 |
Why?
|
Fat Emulsions, Intravenous | 2 | 2013 | 314 | 0.430 |
Why?
|
Fatty Liver | 3 | 2013 | 788 | 0.410 |
Why?
|
Ebstein Anomaly | 3 | 2020 | 105 | 0.410 |
Why?
|
Liver Regeneration | 1 | 2013 | 213 | 0.380 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2024 | 3612 | 0.380 |
Why?
|
Cell Nucleus | 1 | 2020 | 2909 | 0.370 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2014 | 460 | 0.370 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2012 | 226 | 0.360 |
Why?
|
Hypotension | 1 | 2017 | 879 | 0.360 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2448 | 0.340 |
Why?
|
Blood Pressure | 2 | 2017 | 8485 | 0.340 |
Why?
|
Hippocampus | 1 | 2022 | 3763 | 0.340 |
Why?
|
Infant, Newborn | 13 | 2024 | 26211 | 0.330 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2152 | 0.330 |
Why?
|
Bone Remodeling | 1 | 2013 | 581 | 0.330 |
Why?
|
Dopamine | 1 | 2017 | 1605 | 0.330 |
Why?
|
Synapses | 2 | 2023 | 1769 | 0.330 |
Why?
|
AIDS Serodiagnosis | 3 | 2011 | 220 | 0.330 |
Why?
|
Blood Vessels | 1 | 2015 | 1113 | 0.330 |
Why?
|
Pancreaticoduodenectomy | 1 | 2012 | 508 | 0.320 |
Why?
|
Seizures | 1 | 2021 | 2956 | 0.310 |
Why?
|
Bioterrorism | 1 | 2009 | 144 | 0.310 |
Why?
|
Immunity, Innate | 1 | 2020 | 3060 | 0.310 |
Why?
|
Wounds and Injuries | 4 | 2014 | 2490 | 0.310 |
Why?
|
Ultrasonography, Prenatal | 5 | 2017 | 1755 | 0.300 |
Why?
|
Pancreatectomy | 1 | 2012 | 810 | 0.300 |
Why?
|
Laboratories, Hospital | 1 | 2009 | 193 | 0.290 |
Why?
|
Disease Models, Animal | 7 | 2024 | 18234 | 0.280 |
Why?
|
Genomics | 2 | 2022 | 5817 | 0.280 |
Why?
|
Communicable Diseases, Emerging | 1 | 2009 | 150 | 0.280 |
Why?
|
Sentinel Surveillance | 1 | 2009 | 292 | 0.280 |
Why?
|
Lipid Metabolism | 1 | 2015 | 1900 | 0.270 |
Why?
|
Pregnancy Complications | 1 | 2020 | 2947 | 0.270 |
Why?
|
Anemia, Sickle Cell | 1 | 2015 | 1064 | 0.270 |
Why?
|
False Positive Reactions | 1 | 2009 | 956 | 0.270 |
Why?
|
Pregnancy | 12 | 2024 | 29858 | 0.260 |
Why?
|
Electroencephalography | 1 | 2021 | 6224 | 0.260 |
Why?
|
Metabolome | 1 | 2013 | 987 | 0.260 |
Why?
|
Mice | 17 | 2023 | 81474 | 0.250 |
Why?
|
Anti-Inflammatory Agents | 1 | 2015 | 1809 | 0.250 |
Why?
|
Tricuspid Valve | 2 | 2020 | 413 | 0.250 |
Why?
|
Animals | 23 | 2024 | 168388 | 0.240 |
Why?
|
Fluid Therapy | 3 | 2014 | 581 | 0.240 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1886 | 0.240 |
Why?
|
Protein Biosynthesis | 2 | 2022 | 2114 | 0.230 |
Why?
|
Saliva | 1 | 2009 | 827 | 0.230 |
Why?
|
Lipids | 1 | 2015 | 3341 | 0.230 |
Why?
|
Hospital Mortality | 5 | 2024 | 5291 | 0.230 |
Why?
|
Infusions, Intravenous | 3 | 2014 | 2217 | 0.230 |
Why?
|
Mitral Valve Insufficiency | 1 | 2013 | 1404 | 0.220 |
Why?
|
Amniotic Fluid | 2 | 2024 | 378 | 0.220 |
Why?
|
Metabolomics | 1 | 2013 | 1656 | 0.220 |
Why?
|
Dietary Supplements | 3 | 2015 | 3413 | 0.220 |
Why?
|
Liver | 4 | 2015 | 7531 | 0.220 |
Why?
|
Disaster Planning | 1 | 2009 | 557 | 0.210 |
Why?
|
Mental Disorders | 1 | 2022 | 6839 | 0.210 |
Why?
|
Quality Indicators, Health Care | 1 | 2012 | 1792 | 0.210 |
Why?
|
Ambulatory Care Facilities | 1 | 2009 | 934 | 0.210 |
Why?
|
Fatty Acids, Essential | 2 | 2013 | 97 | 0.200 |
Why?
|
Neurons | 2 | 2021 | 9458 | 0.200 |
Why?
|
RNA, Small Nuclear | 1 | 2022 | 75 | 0.200 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2170 | 0.200 |
Why?
|
Docosahexaenoic Acids | 3 | 2014 | 908 | 0.200 |
Why?
|
Stents | 1 | 2014 | 3179 | 0.200 |
Why?
|
Stem Cells | 2 | 2024 | 3521 | 0.200 |
Why?
|
Lung | 5 | 2024 | 9994 | 0.200 |
Why?
|
Wound Healing | 1 | 2013 | 2802 | 0.200 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2024 | 450 | 0.190 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2019 | 0.180 |
Why?
|
Plasma | 1 | 2024 | 586 | 0.180 |
Why?
|
Brain | 6 | 2022 | 27103 | 0.180 |
Why?
|
Emergency Medical Services | 4 | 2014 | 1922 | 0.180 |
Why?
|
Mice, Transgenic | 4 | 2023 | 9534 | 0.170 |
Why?
|
Attitude of Health Personnel | 2 | 2012 | 3889 | 0.170 |
Why?
|
Glutamate Decarboxylase | 1 | 2020 | 239 | 0.160 |
Why?
|
Humans | 47 | 2024 | 761326 | 0.160 |
Why?
|
Hypothermia, Induced | 1 | 2024 | 756 | 0.160 |
Why?
|
RNA, Small Interfering | 2 | 2020 | 3428 | 0.160 |
Why?
|
Hormones | 1 | 2022 | 867 | 0.160 |
Why?
|
Sensory Receptor Cells | 1 | 2023 | 513 | 0.150 |
Why?
|
Tauopathies | 1 | 2022 | 320 | 0.150 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2018 | 72 | 0.150 |
Why?
|
Brain Concussion | 2 | 2022 | 1404 | 0.150 |
Why?
|
Blood Transfusion | 1 | 2024 | 1299 | 0.150 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2024 | 844 | 0.140 |
Why?
|
Ventilator Weaning | 1 | 2018 | 163 | 0.140 |
Why?
|
Fetal Diseases | 2 | 2014 | 913 | 0.140 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2021 | 682 | 0.140 |
Why?
|
Female | 28 | 2024 | 392485 | 0.140 |
Why?
|
Mammals | 1 | 2022 | 1132 | 0.140 |
Why?
|
Immunophenotyping | 1 | 2021 | 1870 | 0.140 |
Why?
|
Dietary Fats | 3 | 2012 | 1994 | 0.130 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2018 | 1461 | 0.130 |
Why?
|
Ethical Review | 1 | 2015 | 27 | 0.130 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2018 | 944 | 0.130 |
Why?
|
Soybean Oil | 2 | 2013 | 139 | 0.130 |
Why?
|
Microtubules | 1 | 2021 | 1074 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 997 | 0.130 |
Why?
|
Ligands | 1 | 2022 | 3271 | 0.130 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2014 | 1249 | 0.130 |
Why?
|
Tricuspid Valve Insufficiency | 2 | 2016 | 355 | 0.120 |
Why?
|
Echocardiography | 3 | 2020 | 4991 | 0.120 |
Why?
|
Ductus Arteriosus, Patent | 1 | 2017 | 219 | 0.120 |
Why?
|
Therapies, Investigational | 1 | 2015 | 111 | 0.120 |
Why?
|
Spinal Cord | 1 | 2023 | 1817 | 0.120 |
Why?
|
Cell Differentiation | 3 | 2024 | 11531 | 0.120 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2021 | 1351 | 0.120 |
Why?
|
Rodentia | 1 | 2016 | 262 | 0.120 |
Why?
|
Ethics Committees, Research | 1 | 2015 | 196 | 0.120 |
Why?
|
Heart Bypass, Right | 1 | 2014 | 75 | 0.110 |
Why?
|
Erythrocyte Membrane | 1 | 2015 | 439 | 0.110 |
Why?
|
Cardiotonic Agents | 1 | 2017 | 539 | 0.110 |
Why?
|
Child | 7 | 2022 | 80156 | 0.110 |
Why?
|
Endothelin-1 | 1 | 2015 | 302 | 0.110 |
Why?
|
Visual Pathways | 1 | 2018 | 551 | 0.110 |
Why?
|
Gene Expression Profiling | 2 | 2020 | 9414 | 0.110 |
Why?
|
Emulsions | 1 | 2013 | 153 | 0.110 |
Why?
|
Benzofurans | 1 | 2014 | 139 | 0.110 |
Why?
|
Parenteral Nutrition Solutions | 1 | 2013 | 30 | 0.110 |
Why?
|
Gestational Age | 4 | 2016 | 3576 | 0.110 |
Why?
|
Epoxy Compounds | 1 | 2013 | 137 | 0.110 |
Why?
|
Behavior, Animal | 1 | 2020 | 1878 | 0.100 |
Why?
|
Neurodegenerative Diseases | 1 | 2022 | 1086 | 0.100 |
Why?
|
Heart Septal Defects | 1 | 2013 | 191 | 0.100 |
Why?
|
Retinal Ganglion Cells | 1 | 2018 | 811 | 0.100 |
Why?
|
Epithelial Cells | 1 | 2024 | 3666 | 0.100 |
Why?
|
Lipid Peroxidation | 1 | 2013 | 271 | 0.100 |
Why?
|
Retina | 3 | 2018 | 2656 | 0.100 |
Why?
|
Membrane Lipids | 1 | 2013 | 252 | 0.100 |
Why?
|
Developmental Disabilities | 1 | 2020 | 1508 | 0.100 |
Why?
|
Nutritional Support | 1 | 2013 | 172 | 0.100 |
Why?
|
Heart Ventricles | 2 | 2014 | 3816 | 0.100 |
Why?
|
Male | 22 | 2024 | 360621 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 3 | 2016 | 3630 | 0.090 |
Why?
|
Neurogenesis | 1 | 2018 | 862 | 0.090 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 1017 | 0.090 |
Why?
|
Injections, Intravenous | 1 | 2013 | 1379 | 0.090 |
Why?
|
Sulfones | 1 | 2014 | 447 | 0.090 |
Why?
|
Arachidonic Acid | 1 | 2012 | 427 | 0.090 |
Why?
|
Oligohydramnios | 1 | 2011 | 37 | 0.090 |
Why?
|
HIV Infections | 4 | 2011 | 17346 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2014 | 3543 | 0.090 |
Why?
|
Multivariate Analysis | 1 | 2024 | 12059 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1863 | 0.090 |
Why?
|
Attitude | 1 | 2015 | 775 | 0.090 |
Why?
|
Melanoma, Experimental | 1 | 2014 | 560 | 0.090 |
Why?
|
Mice, Inbred C57BL | 5 | 2022 | 22154 | 0.090 |
Why?
|
Heart Defects, Congenital | 3 | 2016 | 4696 | 0.090 |
Why?
|
Inflammation | 3 | 2024 | 10760 | 0.090 |
Why?
|
Sex Characteristics | 1 | 2020 | 2637 | 0.090 |
Why?
|
Shock, Septic | 1 | 2017 | 768 | 0.090 |
Why?
|
Liver Failure | 1 | 2012 | 250 | 0.090 |
Why?
|
Echocardiography, Doppler | 1 | 2014 | 898 | 0.090 |
Why?
|
Postoperative Care | 1 | 2016 | 1471 | 0.090 |
Why?
|
Wounds, Stab | 1 | 2010 | 72 | 0.090 |
Why?
|
Visual Perception | 1 | 2018 | 1385 | 0.090 |
Why?
|
Axons | 1 | 2018 | 1674 | 0.080 |
Why?
|
Health | 1 | 2012 | 398 | 0.080 |
Why?
|
Referral and Consultation | 1 | 2022 | 3597 | 0.080 |
Why?
|
Amnion | 1 | 2011 | 197 | 0.080 |
Why?
|
Morbillivirus | 1 | 2009 | 3 | 0.080 |
Why?
|
Efficiency | 1 | 2012 | 476 | 0.080 |
Why?
|
Bone Diseases, Metabolic | 1 | 2013 | 409 | 0.080 |
Why?
|
Retrospective Studies | 9 | 2024 | 80575 | 0.080 |
Why?
|
Phospholipids | 1 | 2013 | 786 | 0.080 |
Why?
|
Immobilization | 1 | 2010 | 227 | 0.080 |
Why?
|
Measles Vaccine | 1 | 2009 | 80 | 0.080 |
Why?
|
Fish Oils | 1 | 2012 | 483 | 0.080 |
Why?
|
Health Care Surveys | 2 | 2012 | 2426 | 0.080 |
Why?
|
Acetaminophen | 1 | 2012 | 554 | 0.080 |
Why?
|
Dyslipidemias | 1 | 2015 | 868 | 0.070 |
Why?
|
Fetal Blood | 1 | 2014 | 1347 | 0.070 |
Why?
|
Diet | 4 | 2012 | 8074 | 0.070 |
Why?
|
Maternal Exposure | 1 | 2014 | 1061 | 0.070 |
Why?
|
Infant, Premature | 2 | 2015 | 2104 | 0.070 |
Why?
|
Prosthesis Design | 1 | 2014 | 2115 | 0.070 |
Why?
|
Hepatectomy | 1 | 2010 | 558 | 0.070 |
Why?
|
Polymers | 1 | 2014 | 1614 | 0.070 |
Why?
|
Measles | 1 | 2009 | 183 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4571 | 0.070 |
Why?
|
New York City | 1 | 2009 | 731 | 0.070 |
Why?
|
Spinal Injuries | 1 | 2010 | 301 | 0.070 |
Why?
|
Time Factors | 5 | 2018 | 39974 | 0.070 |
Why?
|
Infant | 7 | 2023 | 36202 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2013 | 1344 | 0.070 |
Why?
|
Models, Animal | 1 | 2012 | 2112 | 0.060 |
Why?
|
RNA Interference | 1 | 2014 | 2832 | 0.060 |
Why?
|
Administration, Oral | 1 | 2013 | 4013 | 0.060 |
Why?
|
Catheterization | 1 | 2011 | 1432 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2020 | 4477 | 0.060 |
Why?
|
Triglycerides | 1 | 2013 | 2458 | 0.060 |
Why?
|
Fatty Acids | 1 | 2013 | 1806 | 0.060 |
Why?
|
Antioxidants | 1 | 2013 | 1670 | 0.060 |
Why?
|
Rats | 2 | 2024 | 23729 | 0.060 |
Why?
|
Perioperative Care | 1 | 2012 | 1034 | 0.060 |
Why?
|
Gene Expression Regulation | 1 | 2022 | 11900 | 0.060 |
Why?
|
Regeneration | 1 | 2013 | 1511 | 0.060 |
Why?
|
Wounds, Gunshot | 1 | 2010 | 582 | 0.060 |
Why?
|
Software | 1 | 2018 | 4439 | 0.060 |
Why?
|
Pregnancy Outcome | 4 | 2016 | 2920 | 0.050 |
Why?
|
Oxygen | 1 | 2015 | 4227 | 0.050 |
Why?
|
Signal Transduction | 3 | 2024 | 23427 | 0.050 |
Why?
|
Treatment Outcome | 6 | 2016 | 64645 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4432 | 0.050 |
Why?
|
Consensus | 1 | 2012 | 3122 | 0.050 |
Why?
|
Transcription Factors | 1 | 2022 | 12122 | 0.050 |
Why?
|
Patient-Centered Care | 1 | 2012 | 1419 | 0.050 |
Why?
|
Nanoparticles | 1 | 2014 | 1955 | 0.050 |
Why?
|
Neutrophils | 1 | 2015 | 3765 | 0.050 |
Why?
|
Risk Factors | 5 | 2022 | 74152 | 0.050 |
Why?
|
Spinal Cord Injuries | 1 | 2010 | 925 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2013 | 3108 | 0.050 |
Why?
|
Palliative Care | 2 | 2015 | 3592 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2011 | 7872 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8635 | 0.050 |
Why?
|
Quality of Life | 1 | 2022 | 13355 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2022 | 262 | 0.050 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39108 | 0.040 |
Why?
|
Perinatal Mortality | 1 | 2020 | 101 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Child, Preschool | 4 | 2018 | 42251 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2009 | 1762 | 0.040 |
Why?
|
Glycine | 1 | 2022 | 666 | 0.040 |
Why?
|
Arginine | 1 | 2022 | 933 | 0.040 |
Why?
|
Methylation | 1 | 2021 | 1082 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12934 | 0.040 |
Why?
|
Cadherins | 1 | 2023 | 904 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1698 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2016 | 26108 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2009 | 3155 | 0.040 |
Why?
|
Pluripotent Stem Cells | 1 | 2024 | 800 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10431 | 0.040 |
Why?
|
Neuroprotective Agents | 1 | 2024 | 957 | 0.040 |
Why?
|
Blood Flow Velocity | 1 | 2020 | 1370 | 0.030 |
Why?
|
Inflammasomes | 1 | 2022 | 525 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2024 | 1598 | 0.030 |
Why?
|
Abortion, Eugenic | 1 | 2015 | 39 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2018 | 855 | 0.030 |
Why?
|
Endonucleases | 1 | 2018 | 369 | 0.030 |
Why?
|
Cell Lineage | 1 | 2024 | 2556 | 0.030 |
Why?
|
Health Services Accessibility | 1 | 2012 | 5439 | 0.030 |
Why?
|
Adult | 8 | 2022 | 221122 | 0.030 |
Why?
|
United States | 3 | 2012 | 72317 | 0.030 |
Why?
|
Protein Engineering | 1 | 2018 | 550 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2020 | 1265 | 0.030 |
Why?
|
Pericardial Effusion | 1 | 2015 | 247 | 0.030 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 176 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2020 | 1037 | 0.030 |
Why?
|
Epoxide Hydrolases | 1 | 2013 | 122 | 0.030 |
Why?
|
Fetal Death | 1 | 2014 | 435 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2012 | 393 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2579 | 0.020 |
Why?
|
Research Personnel | 1 | 2015 | 588 | 0.020 |
Why?
|
Growth | 1 | 2012 | 365 | 0.020 |
Why?
|
Micronutrients | 1 | 2013 | 381 | 0.020 |
Why?
|
Diet, Fat-Restricted | 1 | 2012 | 329 | 0.020 |
Why?
|
Adipogenesis | 1 | 2012 | 368 | 0.020 |
Why?
|
Genome | 1 | 2018 | 1740 | 0.020 |
Why?
|
Prospective Studies | 1 | 2014 | 54405 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 983 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2012 | 605 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2018 | 15835 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2012 | 540 | 0.020 |
Why?
|
Macrophages | 1 | 2024 | 5768 | 0.020 |
Why?
|
Eye | 1 | 2013 | 710 | 0.020 |
Why?
|
Infant, Premature, Diseases | 1 | 2015 | 710 | 0.020 |
Why?
|
Infant Mortality | 1 | 2014 | 759 | 0.020 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2012 | 370 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2018 | 4280 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6086 | 0.020 |
Why?
|
Catheters, Indwelling | 1 | 2011 | 427 | 0.020 |
Why?
|
Zambia | 1 | 2009 | 262 | 0.020 |
Why?
|
Urologic Diseases | 1 | 2011 | 247 | 0.020 |
Why?
|
Sheep | 1 | 2011 | 1440 | 0.020 |
Why?
|
Necrosis | 1 | 2012 | 1605 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2012 | 891 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2012 | 659 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2022 | 12787 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2013 | 1186 | 0.020 |
Why?
|
Birth Weight | 1 | 2015 | 2100 | 0.020 |
Why?
|
Mouth Mucosa | 1 | 2009 | 431 | 0.020 |
Why?
|
Survival Rate | 2 | 2011 | 12710 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13251 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7582 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 3590 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2012 | 1791 | 0.020 |
Why?
|
Informed Consent | 1 | 2011 | 1008 | 0.010 |
Why?
|
Prognosis | 2 | 2016 | 29588 | 0.010 |
Why?
|
Continuity of Patient Care | 1 | 2011 | 1069 | 0.010 |
Why?
|
Phenotype | 1 | 2021 | 16603 | 0.010 |
Why?
|
Counseling | 1 | 2011 | 1546 | 0.010 |
Why?
|
Cell Membrane | 1 | 2012 | 3687 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14409 | 0.010 |
Why?
|
Bone and Bones | 1 | 2012 | 2568 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12450 | 0.010 |
Why?
|
Age Factors | 1 | 2018 | 18401 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8837 | 0.010 |
Why?
|
Guideline Adherence | 1 | 2011 | 2221 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15599 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10764 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11070 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13500 | 0.010 |
Why?
|
Vitamin D | 1 | 2013 | 3304 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8470 | 0.010 |
Why?
|
Young Adult | 2 | 2015 | 59196 | 0.010 |
Why?
|
Kidney | 1 | 2013 | 7049 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 16966 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 7999 | 0.010 |
Why?
|
Mass Screening | 1 | 2011 | 5428 | 0.010 |
Why?
|
Cognition | 1 | 2012 | 6987 | 0.010 |
Why?
|
Comorbidity | 1 | 2009 | 10498 | 0.010 |
Why?
|
Prevalence | 1 | 2009 | 15719 | 0.010 |
Why?
|
HIV-1 | 1 | 2009 | 6860 | 0.010 |
Why?
|
Adolescent | 1 | 2014 | 88305 | 0.000 |
Why?
|
Neoplasms | 1 | 2014 | 22158 | 0.000 |
Why?
|